These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1920 related items for PubMed ID: 19430340

  • 1. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M.
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [Abstract] [Full Text] [Related]

  • 2. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society.
    Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103
    [Abstract] [Full Text] [Related]

  • 3. Why a consensus conference on hormone replacement therapy and the cardiovascular system?
    Benagiano G, Farris M.
    Maturitas; 2004 Apr 15; 47(4):245-53. PubMed ID: 15063475
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec 15; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 5. [Historical perspective of hormone replacement therapy].
    Chanson P.
    Rev Prat; 2005 Feb 28; 55(4):369-75. PubMed ID: 15828614
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan 28; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy in postmenopausal women.
    Yasui T, Uemura H, Takikawa M, Irahara M.
    J Med Invest; 2003 Aug 28; 50(3-4):136-45. PubMed ID: 13678382
    [Abstract] [Full Text] [Related]

  • 8. Benefits of hormone replacement therapy--overview and update.
    Calaf i Alsina J.
    Int J Fertil Womens Med; 1997 Aug 28; 42 Suppl 2():329-46. PubMed ID: 9397382
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
    Boraz MA, Simkin-Silverman LR, Wing RR, Meilahn EN, Kuller LH.
    Prev Med; 2001 Aug 28; 33(2 Pt 1):108-14. PubMed ID: 11493043
    [Abstract] [Full Text] [Related]

  • 10. Medical issues and hormone replacement therapy.
    Harris PF.
    Curr Womens Health Rep; 2002 Oct 28; 2(5):373-81. PubMed ID: 12215310
    [Abstract] [Full Text] [Related]

  • 11. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC.
    Maturitas; 2007 May 20; 57(1):31-4. PubMed ID: 17383835
    [Abstract] [Full Text] [Related]

  • 12. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul 20; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 13. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH, van der Graaf Y.
    Ned Tijdschr Geneeskd; 2002 Nov 09; 146(45):2127-30. PubMed ID: 12474550
    [Abstract] [Full Text] [Related]

  • 14. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
    Korljan B, Bagatin J, Kokić S, Berović Matulić N, Barsić Ostojić S, Deković A.
    Med Hypotheses; 2010 Jan 09; 74(1):162-3. PubMed ID: 19665311
    [Abstract] [Full Text] [Related]

  • 15. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE, Baer-Dubowska W.
    Acta Pol Pharm; 2005 Jan 09; 62(3):241-7. PubMed ID: 16193819
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU, Ridker PM, Manson JE.
    Thromb Haemost; 1997 Jul 09; 78(1):770-80. PubMed ID: 9198254
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy in postmenopausal women.
    Prelevic GM, Kocjan T, Markou A.
    Minerva Endocrinol; 2005 Mar 09; 30(1):27-36. PubMed ID: 15877011
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O, Metsä-Heikkilä M.
    Gynecol Endocrinol; 2002 Dec 09; 16(6):469-78. PubMed ID: 12626034
    [Abstract] [Full Text] [Related]

  • 19. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD.
    Ann N Y Acad Sci; 2005 Jun 09; 1052():57-74. PubMed ID: 16024751
    [Abstract] [Full Text] [Related]

  • 20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M.
    J Insur Med; 1996 Jun 09; 28(1):27-34. PubMed ID: 10172866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 96.